Butterfly Network (BFLY) recently appointed Arun Nagdev, MD as Chief Medical Officer for Point of Care Ultrasound, placing a seasoned clinician and ultrasound specialist at the center of its global medical and product validation strategy.

The appointment of Dr. Nagdev comes as Butterfly Network’s 1 month share price return of 31.63% and 90 day share price return of 19.72% contrast with a 5 day pullback, while the 1 year total shareholder return of 115% highlights how sentiment has shifted over a longer horizon.

If this healthcare AI story has your attention, it can be useful to compare it with other opportunities in the space by checking out 32 healthcare AI stocks

With Butterfly’s shares up strongly over the past year and the price sitting only modestly below the average analyst target, the key question for you is whether there is still upside here or if the market already reflects future growth.

Most Popular Narrative: 187% Overvalued

At a last close of $5.16 versus a narrative fair value of $1.80, according to Gil263 the market price and the story behind Butterfly Network are far apart.

In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.

Curious how a story built around ultrasound on a chip, new software platforms and future profit margins leads to a much lower fair value than today’s price.

Result: Fair Value of $1.80 (OVERVALUED)

However, this story can shift quickly if revenue growth of 15.57% stalls, or if ongoing net losses of US$77.064 million weigh more heavily on sentiment.

Next Steps

Sentiment in this story is mixed, with both clear concerns and clear upside potential. Act quickly, review the facts, and weigh up the 1 key reward and 3 important warning signs.

Looking for more investment ideas?

If Butterfly Network has you thinking more broadly about where to put your money to work, do not stop here. Line up your next ideas with a few focused screens.

• Zero in on potential value opportunities by scanning 53 high quality undervalued stocks, which combine quality fundamentals with pricing that may not fully reflect them yet.
• Prioritize resilience by reviewing 72 resilient stocks with low risk scores, which show lower overall risk profiles based on a range of fundamental checks.
• Hunt for potential early standouts by checking the screener containing 25 high quality undiscovered gems, which pair solid financial underpinnings with less market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.